Atlas Trials

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

Clinical trial NCT02519816 · UNKNOWN

Trial details

NCT number
NCT02519816
Sponsor
daphne brockington
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic GVHD After HCT for Cancer or Immune Disease
Start date
2016-03-01
Primary completion
2020-01-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.